Loading…

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2024-07, Vol.42 (4), p.e3296-n/a
Main Authors:	Suo, Xiaohui, Fang, Zheng, Wang, Dongmei, Zhao, Liyun, Liu, Jie, Li, Hong, Ma, Xiaojun, Zhang, Congcong, Zhao, Xuemei, Shi, Rui, Wu, Yan, Jiao, Zongjiu, Song, Jiaojie, Zhang, Ling, Li, Ling, Zhang, Suping, Lu, Xinxiao, Yuan, Linyu, Gao, Sifeng, Zhang, Jilei, Liu, Kaiqi, Zhao, Xingli, Bai, Guanchen, Mi, Yingchang
Format:	Article
Language:	English
Subjects:	Acute myeloid leukemia Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - administration & dosage Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Cytarabine Cytarabine - administration & dosage Cytarabine - therapeutic use Daunorubicin Daunorubicin - administration & dosage Female Humans Leukemia Leukemia, Myeloid, Acute - drug therapy Male Middle Aged Sulfonamides - administration & dosage Sulfonamides - therapeutic use
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!